What's New in Pathogenesis & Mechanisms? Drivers of Disease 

At SID 2024 | May 15, 2024 | 8:00 AM - 12:00 PM Central Time 

Hilton Anatole | 2201 N Stemmons Fwy | Dallas, TX, 75207 USA | Cortez Ballroom C&D

Join us as this session aims to provide an update on breakthroughs in the field. Renowned experts will guide attendees through the intricate molecular and immunological processes underlying AD, shedding light on novel insights into disease development. From genetic predispositions to environmental triggers, the session will provide a holistic perspective on the multifaceted nature of AD. Participants will gain valuable knowledge on emerging therapeutic targets and potential interventions, fostering a deeper understanding of how these mechanisms shape the course of Atopic Dermatitis. 

DOWNLOAD THE PROGRAM GUIDE 

WATCH ON-DEMAND WEBCAST - PART 1 (1:44:44)

WATCH ON-DEMAND WEBCAST - PART 2 (1:56:01)

LEARNING OBJECTIVES

• Demonstrate the ability to discuss the relationship between neuroinflammation and atopic dermatitis, including its implications for therapeutic interventions.
• Evaluate and apply evidence-based strategies for atopic dermatitis prevention while utilizing knowledge of mechanisms and biomarkers.
• Analyze the impact of atopic epithelia and skin immune abnormalities on clinical disease severity in type 2 diseases

PROGRAM CHAIRS

Emma Guttman, MD PhD Icahn School of Medicine at Mount Sinai, NY, NY Director, Past-President and Co-Founder		Carolyn Jack, MDCM PhD FRCPC McGill University, Quebec, Canada IEC Associate

AGENDA 

8:00 – 8:10 AM Welcome from the IEC
Lawrence F. Eichenfield, MD | IEC President Elect | University of California, San Diego/Rady Children's Hospital | San Diego, CA, USA

8:10 – 8:15 AM Program Overview
Emma Guttman, MD PhD | IEC Director, Past-President and Co-Founder | Icahn School of Medicine at Mount Sinai | New York, NY

8:15 – 8:45 AM Epithelial barrier and immune biomarkers in type 2 diseases and their association with disease severity
Emma Guttman, MD PhD | IEC Director, Past-President and Co-Founder | Icahn School of Medicine at Mount Sinai | New York, NY

8:45 – 9:15 AM The link between neuroinflammation and AD
Gil Yosipovitch, MD FAAD | IEC Councilor | University of Miami | Miami, FL

9:15 – 9:45 AM Mechanisms and biomarkers of AD Prevention | Pre-Recorded
Alan Irvine, MD DSc | IEC President | Dublin, Ireland

9:45 - 10:00 AM BREAK

10:00 – 10:30 AM Navigating big and/or meta data in AD
Patrick Brunner, MD | IEC Councilor | Icahn School of Medicine at Mount Sinai | NY, NY, USA

10:30 – 11:00 AM SID Abstract: IL-13 protein concentrates in the epidermis of lesional and non-lesional skin of AD patients
Carolyn Jack, MDCM PhD FRCPC | IEC Associate | McGill University | Quebec, Canada

11:00 – 11:15 AM SID Abstract: Using facial skin artificial intelligence (AI) to capture eczema patients’ response to therapy— a single-center prospective study
Shirley P. Parraga, BS | Wake Forest University School of Medicine | Winston-Salem, NC

11:15 – 11:30 AM SID Abstract: Effects of commonly used topical moisturizers on the survival of staphylococcus aureus and staphylococcus hominis A9: Key contributors to the atopic dermatitis microbiome
Austin Moon, MD | University of California San Diego

11:30 – 12:00 PM Discussion Panel Q&A with Speakers & Adjourn | All Speakers

This educational symposium presented by the IEC is offered at no cost to attendees.

HEALTH AND SAFETY TRAVEL RESOURCES

IEC will comply with SID and local mandates at the time of the in-person meeting.